Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
45,215.00
44,058.00
55,170.00
39,490.00
18,446.00
20,533
Depreciation, Depletion & Amortization
707.00
818.00
712.00
255.00
192.00
159
Other Funds
3,578.00
4,053.00
16,017.00
3,155.00
3,257.00
5,155
Funds from Operations
40,930.00
39,187.00
38,441.00
36,080.00
21,511.00
15,219
Changes in Working Capital
476.00
1,982.00
4,937.00
2,491.00
466.00
52
Net Operating Cash Flow
40,454.00
41,169.00
33,504.00
33,589.00
21,045.00
15,271
Capital Expenditures
608.00
780.00
458.00
281.00
24.00
Sale of Fixed Assets & Businesses
-
-
270.00
27.00
-
Net Investing Cash Flow
608.00
780.00
188.00
254.00
24.00
Issuance/Reduction of Debt, Net
29,475.00
80.00
5,062.00
-
1,400.00
Net Financing Cash Flow
100,453.00
377.00
27,703.00
709.00
17,296.00
Net Change in Cash
59,391.00
41,572.00
5,989.00
33,134.00
3,773.00
Free Cash Flow
41,062.00
41,949.00
33,962.00
33,870.00
21,069.00
Change in Capital Stock
70,978.00
457.00
32,765.00
709.00
15,896.00

About Windtree Therapeutics

View Profile
Address
2600 Kelly Road
Warrington Pennsylvania 18976
United States
Employees -
Website http://www.windtreetx.com
Updated 07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.